INS and metabolic dysfunction-associated steatotic liver disease: We have recently demonstrated that this model system recapitulates critical aspects of NAFLD progression, including lipid accumulation, stellate cell activation, and the production of pro-inflammatory cytokines and fibrotic markers, using media containing key NAFLD drivers, including increased levels of glucose, insulin, and free fatty acids [16,41] (Figure S4B; Methods).